Linacip E 5/25 Tablet
By Linacip E
Rx
10 Tablet in a Strip

Composition
Empagliflozin(25mg) + Linagliptin(5mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
June, 2026

liver
Linacip E 5/25 Tablet is considered safe for use in individuals with liver disease. It is generally well-tolerated and does not usually require any dosage adjustments. Nevertheless, caution should be exercised when using Linacip E 5/25 Tablet in cases of severe hepatic impairment, as there is limited data from studies conducted in such circumstances. It is advisable to consult with a healthcare professional before using this medication if you have severe liver issues.

kidney
Linacip E 5/25 Tablet requires caution in patients with kidney disease. Adjusting the dose may be necessary. Avoid use in severe kidney disease or during dialysis. Kindly consult your doctor.

alcohol
It is not safe to drink alcohol when taking Linacip E 5/25 Tablet.

driving
It is unknown if Linacip E 5/25 Tablet affects driving. Refrain from driving if you have symptoms that impact concentration and reaction time.

pregnancy
Linacip E 5/25 Tablet may not be safe to use during pregnancy. Animal studies have indicated potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. It is advisable to consult your doctor regarding its use.

breastfeeding
Caution should be taken while breastfeeding if you are considering using Linacip E 5/25 Tablet. Limited data indicates potential risk of the drug passing into breastmilk and harming the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹189.9
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024